The Long-COVID-Network “DiReNa” stands for medical diagnostics, rehabilitation as well as aftercare and offers a contact point for people suffering from long-term effects of COVID-19. The 4 regional centers in Brandenburg have the necessary medical qualifications and act as contact points. For more information, please visit: www.direna.de
CellTrend offers new antibodies for Long-Covid patients. The PAR1 (thrombin receptor) antibody as a biomarker for thrombotic events (embolism, stroke, myocardial infarction), antibodies against the chemokine receptor CXCR3 and antibodies against the scavenger protein STABILIN-1 as risk parameters for cardiac events. These 3 new biomarkers are now available on our request form!
The article about autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity is published. In this new study of 246 individuals the IgG autoantibodies against 14 different GPCRs were detected with CellTrend kits. The production of these autoantibodies is deregulated in COVID-19. Patients with moderate and severe disease have higher levels of autoantibodies than…
We also support the people from Ukraine affected by the war with a donation to the Evangelisches Jugend- und Fürsorgewerk! The EJF mobilizes numerous own locations for the accommodation of people fleeing from the war in Ukraine. Donations are e. g. needed, to equip the facilities with new furniture, hygiene articles and children’s toys. You…
The U10 team Team Förde from Eckernförde with coach Mario Barbarino is now supported by CellTrend. We are very happy about it, let’s go guys!
Please note that our laboratory will be closed from 22.12.2021 until 02.01.2022. From 3rd January 2022 we will be back for you as usual! The last sample determination this year will take place in the 50th calendar week. Please do not send your samples to us during our holidays! Thank you!
Due to the increased demand for the determination of the anti-ACE-II and MAS1 receptor auto-antibodies, we will measure them at regular intervals. There is also an updated request form available now.
Prof. Dr. Yehuda Shoenfeld has opened the Center for Autoimmune Diseases and Post-Covid Syndrome in St. Petersburg.
In the week from 07-10.09. the meanwhile 15th symposium on autoantibodies took place in Dresden. Dr. Harald Heidecke spoke about PAR1 autoantibodies as a potential biomarker for a severe course of Covid-19. .
Soon we will have 1,000 samples full in 2021. We have thought about this: The 1,000th invoice receives a 50% discount. Being fast is worth it!